Most AI writing tools dump a chapter into chat and call it done.
NovelCraft keeps suggestions as ghost text until you Tab. Keep typing and they vanish.
Help on one stuck sentence — not a new book in someone else’s voice.
Start writing free → https://t.co/o0GvjUgFuU
I agree with Dario that we need to pace the frontier. This has been a primary topic of discussions we've had at OpenAI in recent weeks.
Committing to having independent evaluators with employee-like access is a great idea, and we will do the same. We'll have more to share soon.
We Must Pace the Frontier: I’ve written a new essay on why the AI industry should slow down, with a three-part plan for doing so.
Anthropic is unilaterally committing to the first of these steps. We’ll provide third-party evaluators with permanent, employee-level access to our systems, so that they can verify adherence to our safety measures, report on incidents, and assess models’ alignment during training.
You can read the full post here: https://t.co/OGyPb7yaYt
I resigned from Anthropic today. I spent the last three years doing pretraining research at both OpenAI and Anthropic. Neither company is acting responsibly. They are racing straight to self-improving superintelligence and gambling with our lives. More thoughts below.
GPT-6 Astra is a complete beast at reverse engineering games. Gave it 2 hours while I was at the gym, and now I can play The Legend of Zelda: The Wind Waker on my phone 😎
Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per target, sifting through a large number of candidates to identify the few that work.
We wanted to test if Claude could successfully design novel protein binders from scratch (also called de novo design). With a protein design prompt written by a human expert, Claude autonomously designed protein binders against 14 out of 15 targets.
We then worked with Adaptyv Bio and Twist Bioscience, who independently built and tested the proteins Claude designed.
Beta testers wanted.
Arcana is a new trading card game just opened to the public.
Play, break things, tell us what you think:
https://t.co/IXgwwTTcTB
Early players get bragging rights 👀